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Abstract: Poultry frequently account for the highest prevalence of extended-spectrum beta-lactamase
(ESBL)-producing Enterobacteriaceae in livestock. To investigate the impact of direct-fed microbials
(DFM) and phytobiotic feed additives on prevalence and conjugation of extended-spectrum
beta-lactamase (ESBL)-producing Enterobacteriaceae, an animal trial was conducted. Lactobacillus agilis
LA73 and Lactobacillus salivarius LS1 and two commercial phytogenic feed additives (consisting of
carvacrol, cinnamaldehyde, and eugenol) were used as feed additives either alone or as a combination
of DFM and phytogenic feed additive. An ESBL-producing E. coli donor and a potentially pathogenic
Salmonella Typhimurium recipient were inoculated at 5× 109 cells/mL in cecal contents from 2-week-old
broilers. Conjugation frequencies were determined after 4 h aerobic co-incubation at 37 ◦C and
corrected for the impact of the sample matrix on bacterial growth of donor and recipient. Surprisingly,
indigenous Enterobacteriaceae acted as recipients instead of the anticipated Salmonella recipient.
The observed increase in conjugation frequency was most obvious in the groups fed the combinations
of DFM and phytogenic product, but merely up to 0.6 log units. Further, cecal samples were
examined for ESBL-producing Enterobacteriaceae on five consecutive days in broilers aged 27–31 days.
All samples derived from animals fed the experimental diet showed lower ESBL-prevalence than the
control. It is concluded that Lactobacillus spp. and essential oils may help to reduce the prevalence of
ESBL-harboring plasmids in broilers, while the effect on horizontal gene transfer is less obvious.
Keywords: extended-spectrum ß-lactamases; ESBL; phytobiotics; probiotics; essential oils;
Lactobacillus; plasmid transfer; horizontal gene transfer; stress impact; conjugation
1. Introduction
Broiler chickens are the livestock with the highest prevalence of extended-spectrum beta-lactamase
(ESBL)-producing Enterobacteriaceae in many regions of the world. In this context, E. coli and Salmonella
spp. are the bacteria most commonly identified as the host of bla (ESBL encoding genes) carrying
plasmids [1]. Transmission of ESBL-producing bacteria between animals happens rapidly and
undetected, as no specific symptoms accompany the inoculation and establishment of ESBL-producing
Enterobacteriaceae in broilers. These primarily non-pathogenic bacteria can, however, transfer mobile
genetic elements to pathogenic bacteria and thereby cause infections, which are difficult to cure [2–5].
As they also may be transmitted to humans, these multi-resistant bacteria pose a major hazard to
public health, causing tremendous costs worldwide [6–9].
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As the problem gained global attention and the importance to intervene in the development and
spread of antibiotic-resistant bacteria has gained high political priority, different measurements were
developed to reduce the prevalence of ESBL-producing bacteria [8,10,11]. One possible approach to
reduce the ESBL prevalence may be the use of feed additives, such as direct-fed microbials (DFM) or
phytogenic feed additives [12,13]. The negative impact of DFMs, such as various Lactobacillus strains,
on the prevalence of pathogens has been described frequently [12,13]. To our best knowledge, only
three studies demonstrating the impact of DFMs and competitive exclusion cultures on prevalence and
transfer of ESBL-producing Enterobacteriaceae in broilers have been published [14–16]. These studies
comprise commercial products and competitive exclusion cultures, however no exact qualitative and
quantitative specification of the containing microorganisms was provided.
Phytogenic products are used in poultry farming due to their beneficial impact on health and
production [13,17]. These products can be grouped into four categories: herbs, botanicals, essential oils,
and oleoresins [18]. Antibacterial activities against pathogens such as Salmonella spp. and E. coli among
others have been observed in various essential oils [13,19,20]. Moreover, phytogenic feed additives
were associated with a reduced plasmid transfer in E. coli [21].
Besides their prevalence, the spread of antibiotic resistance plays an important role in the
dissemination of ESBL-producing Enterobacteriaceae. On the one hand, the transmission between
animals and from animals to humans must be considered. Several studies have targeted this topic with
one trial specifically covering the transmission of ESBL-producing Enterobacteriaceae between broilers
receiving DFM [16]. On the other hand, horizontal gene transfer of ESBL-carrying plasmids must also
be considered as antibiotic resistance genes are frequently exchanged between bacteria [22,23].
Thus, the approach of this study was to use DFMs with previously characterized components
(qualitatively and quantitatively) as well as phytogenic products to reduce the prevalence and
conjugation frequency of ESBL-producing Enterobacteriaceae. Results were obtained from in vivo (ESBL
prevalence) and ex vivo (conjugation) experiments to investigate the natural occurrence and spread of
ESBL genes as well as conjugation between artificially added strains.
2. Materials and Methods
2.1. Animals and Husbandry
For the animal trial, newly hatched male Cobb 500 broiler chicks were randomly allocated to
nine feeding groups with seven replicates each and reared for five weeks. Three animals were reared
together in cages of 50 × 35 × 68 cm (depth × width × height) for two weeks, subsequently, the animal
density was reduced to 1–2 animals per cage. Metal walls separating cages reduced the contact between
animals. As the cage floor comprised a metal net, excreta were automatically excluded from the animals’
environment, reducing the contact of the animals with the excreta and thereby decreasing the risk for
bacterial contamination. The initial temperature was 34 ◦C for 48 h and reduced by 3 ◦C weekly. After
72 h of constant light, a cycle of 18 h light and 6 h darkness was applied. Water and experimental diet
were constantly available ad libitum. The nine experimental diets comprised a control diet (Table 1),
two diets supplemented with Lactobacillus salivarius LS1 or Lactobacillus agilis LA73 (1010 cfu per kg
feed) [24], two experimental diets were supplemented with the phytogenic products Formulation
C or Formulation L (250 mg/kg feed; EW Nutrition, Germany) and four diets supplemented with a
combination of one DFM and one phytogenic product (Table 2). Formulation C contained the essential
oils carvacrol and cinnamaldehyde, while Formulation L additionally contained eugenol. These feed
additives were chosen due to their ability to reduce the viability of the ESBL-producing E. coli strain
ESBL10716 in a previous in vitro experiment [25]. The animal trial was approved by the Regional
Office for Health and Social Affairs Berlin (LaGeSo Reg. A 0437/17).
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Soybean meal 49% CP 323.3
Soybean oil 59.5






Skim milk powder 0.3
Nutrient Composition
Crude Protein (%) 22.00
Crude Fat (%) 8.19






Calculated Apparent Metabolizable Energy
AMEN (MJ/kg) 2) 12.6
1) Contents per kg diet: 4800 IU vit. A; 480 IU vit. D3; 96 mg vit. E (α-tocopherole acetate); 3.6 mg vit. K3;
3 mg vit. B1 ; 3 mg vit. B2; 30 mg nicotinic acid; 4.8 mg vit. B6; 24 µg vit. B12; 300 µg biotin; 12 mg calcium
pantothenic acid; 1.2 mg folic acid; 960 mg choline chloride; 60 mg Zn (zinc oxide); 24 mg Fe (iron carbonate); 72 mg
Mn (manganese oxide); 14.4 mg Cu (copper sulfate-pentahydrate); 0.54 mg I (calcium Iodate; 0.36 mg Co (cobalt-
(II)-sulfate-heptahydrate); 0.42 mg Se (sodium selenite); 1.56 g Na (sodium chloride); 0.66 g Mg (magnesium oxide).
2) Nitrogen-corrected apparent metabolizable energy estimated from chemical composition of feed ingredients
(based on the EU Regulation - Directive 86/174/EEC): 0.1551 × % crude protein + 0.3431 × % ether extract + 0.1669 ×
% starch + 0.1301 × % total sugar.
Table 2. Feed additives applied to feed groups.
Feed Group Diet Supplementation
Control None
LS DFM 1:1010 cfu Lactobacillus salivarius LS1/kg diet
LA DFM 2: 1010 cfu Lactobacillus agilis LA73/kg diet
Formulation C Phytogenic product 1: 0.25 g Formulation C/kg diet
Formulation L Phytogenic product 2: 0.25 g Formulation L/kg diet
LS + C 0.25 g Formulation C + 1010 cfu Lactobacillus salivarius LS1/kg diet
LS + L 0.25 g Formulation L + 1010 cfu Lactobacillus salivarius LS1/kg diet
LA + C 0.25 g Formulation C + 1010 cfu Lactobacillus agilis LA73/kg diet
LA + L 0.25 g Formulation L + 1010 cfu Lactobacillus agilis LA73/kg diet
2.2. Strains and Cultivation Conditions
The experimental design comprised the ESBL-producing donor strain Escherichia coli ESBL10682,
derived from broiler excreta within the RESET program [26]. This strain belonged to the phylogenic
group B1 and produced the enzyme CTX-M-1. Furthermore, the strain Salmonella Typhimurium
L1219-R32 served as the recipient. Susceptibility of donor and recipient against various antibiotics was
investigated by disc diffusion test (Table S1 Saliu et al., manuscript submitted). This conjugative pair
was known to transfer plasmids in vitro at a conjugation frequency (CF) of 10−4–10−5 when incubated
in Mueller Hinton 2 Broth (Sigma-Aldrich, Chemie GmbH, Germany) for 4 h [27]. All samples were
cultivated aerobically at 37 ◦C for 4 h.
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2.3. Collection of Samples
Pooled excreta samples were collected weekly from each experimental group. During days 13–17,
these samples were derived from the cages used for the conjugation experiment only. The samples
from the last collection originated from fewer cages as several animals had been sacrificed according
to the trial design. At all remaining time points, all cages were sampled. After dilution with equal
volumes of sterile glycerol (50% Glycerol, Carl Roth GmbH + Co. KG, Germany, 50% Phosphate
Buffered Saline (PBS), Sigma-Aldrich Chemie GmbH, Germany), the samples were stored at −80 ◦C
until further analyzed.
Two animals of each feeding group were sacrificed per day by cervical dislocation subsequent
to anesthesia from day 13 to 17. The ceca were removed, immediately transferred to the laboratory
facilities, and the content was collected. This procedure was repeated with one animal per feeding
group and day on days 27–31.
2.4. Conjugation Experiments
The donor and recipient strains were cultivated in Mueller Hinton 2 Broth supplemented
with 8 µg/mL cefotaxime (CTX; Alfa Aesar, Thermo Fisher GmbH, Germany) or 300 µg/mL
sulfamethoxazole/trimethoprim (SXT, Sigma-Aldrich, Chemie GmbH, Germany) respectively for
19 h. After washing the cells twice in PBS, cell concentrations were obtained photometrically and
adjusted to 5×109 cells/mL. Cecal samples were diluted 10-fold in a citric acid–Na-citrate buffer system
(pH 6.2; Sigma-Aldrich, Chemie GmbH, Germany). Each 50 µL donor and recipient suspension were
added to 900 µL diluted cecal samples in triplicates. The suspensions were thereafter incubated
aerobically for 4 h and plated on selective MacConkey agar (Carl Roth GmbH + Co. KG, Germany)
containing 300 µg SXT and 8 µg CTX per mL agar, to obtain transconjugants, 300 µg SXT/mL agar
for recipient identification or 8 µg CTX/mL agar for the calculation of donor concentrations. CF was
calculated as transconjugants/donor (CF/D) and transconjugants/recipients (CF/R). The negative control
comprised cecal contents without donor or recipient and was plated on MacConkey agar containing
300 µg SXT and 8 µg CTX per mL agar after 4 h incubation.
2.5. Calculation of a Stress Impact Factor
As the sample matrix influences the growth of donor, recipient, and transconjugants, a bias arises
when only evaluating CF based on donor or recipient cfu. Thus, the impact of stressors within the
sample must be considered. A stress impact factor (SIF), correcting the results for this bias, aims to
normalize the differences by incorporating control incubations [27]:
SIF =
mean c f uctr/mL
mean c f ustress/mL
(1)
Here, cfuctr represents the cfu of the control and cfustress stands for the bacterial concentration
(cfu) at a specific level of supplementation with a stress factor. No differences in growth are observed
when the SIF equals 1, while a SIF smaller than 1 occurs when feed additives result in higher bacterial
concentrations. On the other hand, a SIF larger than 1 outlines enhanced bacterial growth in the
presence of the stressor compared to no supplementation. This factor can subsequently be used to
calculate corrected bacterial concentrations (cfucorr), which most likely would be observed in the
absence of the stressor by multiplication of the SIF and cfustress:
cfucorr= cfustress×SIF (2)
SIF corrected CF were thereafter calculated as CF/D (SIF) = cfucorr(transconjugants)/ cfucorr(donor)
and CF/R (SIF) = cfucorr(transconjugants)/ cfucorr(recipient). In the latter, the SIF for transconjugants
equals the SIF for recipients. Hence, CF/R=CF/R (SIF) and CF/R (SIF) can be neglected.
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2.6. Prevalence of ESBL-Producing Enterobacteriaceae
The excreta samples were thawed at room temperature and each 1 g sample was diluted in 4.5 mL
Buffered Peptone Water (BPW, Carl Roth GmbH + Co. KG, Germany) as described previously [28].
The dilutions were plated on multiple MacConkey agar plates containing 2 µg CTX/mL agar as
described previously [29–31] and incubated aerobically at 37 ◦C for 48 h.
A similar procedure was applied for the cecal content samples collected on day 27–31. The cecal
content was diluted in the double amount of PBS and directly spread on MacConkey agar containing
2 µg CTX/mL. The plates were evaluated after 48 h aerobic incubation at 37 ◦C.
No pre-enrichment was conducted, as quantification of ESBL-producing Enterobacteriaceae
was intended.
2.7. Statistics
The software IBM SPSS (Version 22, USA) was used for the statistical analysis of the results.
The results are presented as mean values and standard deviation. To determine significance and
subgroups, the non-parametric Kruskal–Wallis test and Mann–Whitney test were applied for CF
and bacterial growth while the chi-squared test was applied for the prevalence of ESBL-producing
Enterobacteriaceae in the cecal content. Differences at p < 0.05 were considered statistically significant and
p values between 0.05 and 0.1 were accepted as trends. Pearson correlations were applied to identify
correlations between short-chain fatty acid concentrations and CF and were considered significant at
the 0.01 level (2-tailed).
3. Results
3.1. Donor and Recipient Growth
The different feed additives and their combinations did not show a significant impact on Salmonella
Typhimurium L1219-R32 (p = 0.183) or E. coli ESBL10682 (p = 0.317) growth (Table 3). The initial
concentration of approximately 8.7 log cfu/mL cecal content of each donor and recipient strain declined
after 4 h of incubation to 7.5–7.9 log cfu/g cecal content for E. coli ESBL10682 and 7.9–8.4 log cfu
Salmonella Typhimurium/g cecal content while the indigenous, SXT-resistant Enterobacteriaceae showed
concentrations of 6.4–7.1 log cfu/g cecal content. On average, the Salmonella Typhimurium L1219-R32
showed slightly higher growth than the E. coli strain. The lowest growth was observed for SXT
resistant Enterobacteriaceae, which also varied significantly (p = 0.002) between feeding groups (Table 3).
Here, LS + L, LA + C, LA and Formulation C showed significantly lower numbers of SXT resistant
Enterobacteriaceae of up to 0.72 log units than Formulation L or LA + L. However, these were not
significantly lower than the observed amount of SXT resistant Enterobacteriaceae in samples derived
from animals fed the control diet.
3.2. Conjugation Experiments
The donor/recipient pair was known from a previous in vitro study to show CF of
10−5–10−4 transconjugants/donor or transconjugants/recipient after 4 h of co-incubation [27]. In the
aforementioned in vitro set up, a 10-fold lower initial concentration of donor and recipient was chosen
compared to the setup of the present experiment. Still, in the present study, indigenous Enterobacteriaceae
stepped in as plasmid acceptors instead of the intended Salmonella Typhimurium recipient at CF of
10−5–10−4 transconjugants/donor and 10−3 transconjugants/recipient (Table 4). Differences in CFD
(SIF) were observed between different trial groups. The groups receiving feed supplemented with
Formulation C, LS +C, LS + L or LA + L showed significantly higher CF/D (SIF) than the control group
(Table 4). The applied feed additives did not affect CF/R. The negative control did not grow colonies
on plates containing the combination of CTX and SXT or only CTX but on the plates containing SXT.
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Table 3. Impact of direct-fed microbials (DFM) and phytobiotic feed additives on bacterial growth after
4 h incubation of inoculated cecal samples with the donor (E. coli ESBL10682) and recipient (Salmonella
Typhimurium L1219-R32) strains [log10(cfu/mL)].




SXT Resistant Enterobacteriaceae 2
Control 6.86 ± 0.48 7.10 ± 0.37 5.93 ± 0.61 abe
LS 6.81 ± 0.27 7.04 ± 0.39 5.92 ± 0.52 be
LA 6.90 ± 0.45 6.92 ± 0.47 5.49 ± 0.42 abcd
Formulation C 6.94 ± 0.31 7.06 ± 0.42 5.50 ± 0.52 abcd
Formulation L 6.91 ± 0.28 7.36 ± 0.24 6.12 ± 0.80 e
LS + C 6.76 ± 0.54 7.21 ± 0.31 5.85 ± 0.49 abde
LS + L 6.56 ± 0.71 7.14 ± 0.32 5.40 ± 0.64 abcd
LA + C 6.49 ± 0.73 7.10 ± 0.37 5.45 ± 0.68 abcd
LA + L 6.59 ± 0.53 7.14 ± 0.24 6.02 ± 0.51 e
p 1 0.317 0.183 0.002
1 Significant differences were determined using the Kruskal–Wallis test, 2 different letters indicate significant
differences (p < 0.05, Mann–Whitney test) in the abundance of indigenous, SXT resistant Enterobacteriaceae after 4 h
incubation between trial groups.
Table 4. Impact of DFM and phytobiotic feed additives on CF after 4 h incubation of donor (E. coli
ESBL10682) and the recipient (Salmonella Typhimurium L1219-R32) in cecal contents [log10(CF 1)].
Trial Group CF/D 3 CF/R CF/D (SIF) 3
Control −4.43 ± 0.45 ab −3.46 ± 1.01 −4.43 ± 0.45 a
LS −4.21 ± 0.57 b −3.32 ± 0.74 −4.29 ± 0.57 ab
LA −5.07 ± 1.46 a −3.65 ± 1.12 −4.57 ± 1.46 a
Formulation C −4.60 ± 0.40 a −3.16 ± 0.68 −4.20 ± 0.40 b
Formulation L −4.27 ± 0.52 ab −3.48 ± 0.96 −4.66 ± 0.52 a
LS + C −4.10 ± 0.52 b −3.19 ± 0.56 −3.98 ± 0.52 b
LS + L −3.98 ± 0.96 b −2.82 ± 0.71 −3.82 ± 0.96 b
LA + C −3.95 ± 0.55 b −2.90 ± 0.68 −3.98 ± 0.55 b
LA + L −4.10 ± 0.94 b −3.53 ± 0.86 −4.33 ± 0.94 ab
p 2 0.010 0.172 0.031
1 CF = conjugation frequency; 2 significant differences were determined using the Kruskal–Wallis test, 3 different
letters indicate significant differences (p < 0.05, Mann–Whitney test) in conjugation frequency between trial groups
within a column; CF/D = transconjugants/donor; CF/R = transconjugants/recipients; SIF = stress impact factor.
3.3. Prevalence of ESBL-Producing Enterobacteriaceae
ESBL-producing Enterobacteriaceae (ESBL-PE) were detected in the excreta of newly hatched chicks
and throughout the entire rearing period (Table S2). To investigate the day-to-day differences of cecal
ESBL-PE, the fifth week of the feeding trial was monitored closely. Significant differences (p = 0.001)
were observed between feed groups both in regards to the number of days ESBL-PE were above the
detection limit, as well as to the amount of detected ESBL-PE/g cecal content (Table 5). The groups LA
and LS + L were negative at all sampling times. Quantitatively, groups LS + C, LA + L, LS, LA + C,
Formulation C and Formulation L followed. When evaluating the qualitative results, LS + C and LA + L
showed a lower prevalence than LS, LA + C, Formulation C and Formulation L. The ESBL-producing
Enterobacteriaceae were not characterized further, but the microbial composition of the cecal content
was described elsewhere [32].
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Table 5. Impact of probiotic and phytobiotic feed additives on the prevalence of ESBL-producing
Enterobacteriaceae in cecal contents of broilers [cfu/g].
Trial Group
Day
27 28 29 30 31 Prevalence per Trial Group (%)
Control 13 nd 7 8340 nd 60 a
LS 20 nd nd nd 40 40 b
LA nd nd nd nd nd 0 b
Formulation C 13 nd nd nd 80 40 b
Formulation L 7 nd nd 539 nd 40 b
LS + C nd nd 20 nd nd 20 b
LS + L nd nd nd nd nd 0 b
LA + C nd 63 nd 25 nd 40 b
LA + L nd nd nd 7 nd 20 b
Prevalence (%):
positive samples per day 44 11 22 44 22
p 1 0.001
nd: not detected. 1 Significant differences were determined using the chi-squared test, different letters indicate
significant differences (p < 0.05) in the overall prevalence of ESBL-producing Enterobacteriaceae between trial groups.
4. Discussion
The threat that ESBL-producing Enterobacteriaceae from poultry pose to public health must be
taken into serious consideration when discussing antibiotic resistance in farm animals. Different
approaches to reduce the prevalence and spread of these bacteria in poultry by the use of feed additives
showed promising results [14–16,21]. However, to our best knowledge, their impact on both prevalence
and horizontal gene transfer has not been studied in poultry. A previous study by our working
group focused on the identification of lactic acid bacteria and phytogenic products with inhibitory
potentials against the ESBL-producing E. coli ESBL10716 [25]. Subsequently, the current trial followed
to investigate their ability to reduce in vivo prevalence and ex vivo transfer of extended-spectrum
beta-lactam resistance.
To investigate the impact of these feed additives on conjugation frequency, donor and recipient
strains were added to cecal contents obtained from 2-week-old broilers. The initial concentrations of
the donor and recipient strains were chosen at very high levels compared to the common abundance of
bacterial strains in the gastrointestinal tract of broilers [33–35] to investigate the theoretical possibility
of gene transfer, as high concentrations increase the chance of detecting changes. Only a part of the
initial donors and recipients added to the cecal contents were able to establish in the matrix, but E. coli
and Salmonella Typhimurium concentrations still exceeded natural levels of single strains. Here, the
detection of higher concentrations for Salmonella Typhimurium L1219-R32 than E. coli ESBL10682 was
unexpected, as previous in vitro experiments with this mating pair constantly led to reverse results [27].
Apparently, the chosen habitat (cecum) was more favorable for the Salmonella strain.
As both donor and recipient were able to survive the conditions in cecal contents, one would
expect to find transconjugants after 4 h of co-incubation. Surprisingly, the complex system of an
intestinal milieu revealed a tremendous impact on conjugation, as no Salmonella transconjugants could
be recovered. The chosen Salmonella/E. coli mating pair has been established as an excellent system
for in vitro experiments [27]. Furthermore, the growth of the Salmonella strain was also not affected
by the cecal matrix. Therefore, other factors of the cecal matrix may have been present. During
previous in vitro experiments, the simple addition of propionate for instance significantly reduced
conjugation frequencies for the Salmonella/E. coli mating pair [27]. Cecal propionate concentrations were
not significantly different between feed groups (Table S3) [32] and no correlation between propionate
(p = 0.662), acetate (p = 0.96) or total short-chain fatty acids (p = 0.905) and CF/D (SIF) were detected.
Still, this and other factors of the cecal matrix (bacterial competition, quorum sensing molecules,
intermediary metabolites) may have triggered a physiological state in either donor and/or recipient
strain that inhibits the formation of the conjugation machinery [36–38].
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Instead, within the period of 4 h, a time frame resembling the passage time of cecal content
in 14-day-old broilers [39], E. coli donor successfully transferred the blaCTX-M-1 carrying plasmid to
indigenous Enterobaceriaceae. This also leads to the conclusion that conjugation was not inhibited for
the donor and thus, conjugation may have only been inhibited for the Salmonella recipient. As only the
SXT resistant transconjugants were detected, one must expect that further, SXT sensitive enterobacteria
additionally served as recipients and affected the CF observed in this experiment. As the negative
control did not show growth on plates identifying donor or transconjugants, it was concluded that
the chosen donor strain was accountable for the observed transconjugants. Further studies should
investigate longer incubation times, simulating the establishment of donor and recipient in the
gastrointestinal tract. Additionally, a wider screening of recipients should be included.
Comparing conjugation frequencies is a common method applied when evaluating horizontal
gene transfer [40]. To calculate the CF, the amount of transconjugants is either divided by the number
of recipients or donors. Results from the present study display major differences between these
approaches and stress the importance of considering both methods when evaluating plasmid transfer.
Also, the impact of the environment on bacterial growth is frequently neglected. Thereby, a bias
arises [40–42], which was circumvented in the current study by applying the stress impact factor
(SIF). In the present study, the results of SIF correction were rather similar to the CF/D and CF/R
values besides group LA, Formulation C and Formulation L, where differences of 0.5, 0.4, and 0.3 log
cfu/mL were observed, respectively. In these groups, the SIF for transconjugant and recipient growth
were among the most pronounced at 2.8, 2.3, and 0.4 respectively. This highlights the importance of
considering changes in bacterial growth when interpreting results from conjugation trials. Observed
CF/R in this ex vivo setup exceeded results from previous in vitro experiments, while the CF/D was
rather similar to earlier findings [27]. This might be explained by the amount of different possible
indigenous recipients compared to one Salmonella recipient strain.
The lowest detected CF/D (SIF) among indigenous enterobacteria was observed when fed the
experimental diets supplemented with L. agilis or Formulation L. Similarly, it was previously described
that Lactobacillus plantarum strains can reduce CF/R in vitro, independent of their ability to produce
bacteriocins [43]. Similar results were observed in an in vitro trial with Klebsiella pneumoniae (SHV-5)
and Salmonella enterica serovar Typhimurium (CTX-M-15) donors and an Escherichia coli K-12 recipient
in the presence of different Bifidobacterium spp., reducing transconjugant counts with up to 2.6 logs [44].
These results were confirmed in in vivo trials with gnotobiotic mice, where a strain and incubation
time-dependent reduction of transconjugants of up to 3.3 logs was reported. However, no information
is provided on the impact of DFM on horizontal gene transfer of bla in a complex matrix comprising a
diverse microbial community. Compared to the mentioned studies, the reduction of CF observed in
the current study in the presence of L. agilis was less pronounced and statistically not significantly
different from the control. The results from the current study also revealed species-specific differences
as, opposite to L. agilis, L. salivarius induced a slight increase of CF/D, CF/R, and CF/D (SIF) compared
to the control.
The phytobiotic product Formulation C seemed to reduce CF/D, but correction for stress impact
on bacterial growth reversed this into an increase. On the contrary, the observed increase in CF/D
by the group receiving Formulation L was reversed into a decrease when corrected by SIF. Similarly,
components of Thymus vulgaris essential oils reduced the transfer of the bla-carrying pKM101 plasmid
between E. coli strains. The highest reduction was observed as an effect of linalool supplementation,
followed by S- and R-carvone, eugenol, and borneol [21]. This implies that different phytogenic
compounds affect CF differently.
Interestingly, the combination of DFM and phytobiotic feed additives had an enhancing impact
on conjugation frequencies. The only exception was observed for the combination of L. agilis and
Formulation L, where a minor numeric reduction was observed. In summary, a non-significant
reductive impact on conjugation (CF/D (SIF)) was observed for L. agilis and Formulation L, while a
significantly higher CF was detected in Formulation C, LS + C, LS + L, and LA + C than in the control.
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This suggests that the chosen DFM and phytobiotics are unlikely to reduce conjugation frequencies of
the investigated ESBL-carrying plasmid in broilers.
In poultry, ESBL-PE prevalence of up to 100% were previously reported [1]. This corresponds
with findings from excreta samples at week 4, where all samples were tested positive (Table S2).
The early detection of ESBL-PE in newly hatched broiler chicks corresponds with results from the
literature, identifying chicks and eggs as a potential risk factor for transmission between farms [45,46].
In cecal contents, two feed groups were negative for ESBL-PE at all sampling times. Comparing
quantitative and qualitative results from the other feed groups, differences appear. The groups
characterized as equal in the qualitative approach (20% prevalence) showed obvious quantitative
differences. Qualitative evaluation of ESBL-PE prevalence, often after pre-enrichment, is commonly
used to report antimicrobial resistance in poultry [1]. The results of this study suggest that qualitative
evaluations may distort the picture.
It was previously shown in vivo, that DFM can reduce the prevalence of ESBL-producing E. coli in
the ceca of broiler chicks [14,15], corresponding with the results from this in vivo trial. Another study
investigated the transmission of ESBL-producing E. coli (CTX-M-1) between animals, where animals
perceiving the DFMs were less susceptible to ESBL-producing E. coli and excreted lower numbers of these
bacteria [16]. The effect observed in these studies were based on competitive exclusion. In contrast to
the present study, the aforementioned trials performed an ESBL-PE challenge. Additionally, commercial
products comprising a diverse bacterial community, which was not characterized quantitatively, was
used compared to the single-strain approach of the present study.
Besides the impact of the DFM, phytogenic feed additives may have an effect on the prevalence of
ESBL-PE [47,48]. A reduction of ESBL-PE prevalence was observed both qualitatively and quantitatively
in the presence of the phytogenic products in cecal contents. As quantitative differences were observed
between the products, the most severe effect was observed when combined with a DFM strain.
The results of this study displayed differences in the efficiency of different lactobacilli strains and
phytobiotic products regarding the ability to reduce ESBL-PE prevalence and their plasmid transfer.
In addition, no consistent correlation between the ability to reduce the prevalence and the CF was
observed. This suggests that feed additives reducing the ESBL-PE prevalence should be combined with
supplements targeting plasmid transfer to achieve the highest possible reduction of ESBL-producing
bacteria. As this may sound logical in theory, the interaction of combinations may lead to different
results [32]. Thus, it is crucial to determine the combined effect of such products, as they may be
additive but also can neutralize or even reverse the effect of the single components. In this study, only
one combination (LA + L) did not increase CF. With regards to the ESBL-PE prevalence, 2 (LS + C, LS)
of 4 combinations were superior to the quantitative results induced by the DFM supplementation and
all 4 combinations performed better than the single supplementation of phytobiotics. Further studies,
where the broilers are challenged with defined amounts of ESBL-producing E. coli, should be conducted
in the future to compare the results with these results from natural colonization with ESBL-PE.
5. Conclusions
Out of the tested feed additives, the effect of DFM on ESBL-PE prevalence was superior
to the phytobiotic products. L. agilis showed the most promising ability to reduce both the
prevalence of ESBL-producing Enterobacteriaceae as well as the ESBL-carrying plasmid transfer between
Enterobacteriaceae. Combinations of phytogenic additives and DFM did not enhance the effect of the
single components on CF. The impact of DFM and phytobiotic feed additives on conjugation was less
obvious than the impact on ESBL-PE prevalence.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-2607/8/3/322/s1,
Table S1: Susceptibility of donor and recipient strain, Table S2: Prevalence of ESBL-producing Enterobacteriaceae in
the feces of broilers, Table S3: Raw data short-chain fatty acids, Table S4: Raw data.
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